US Institutional Review Board Perspectives Regarding Psychedelic Research
Psychedelic Medicine April 23, 2026 Jill Oliver Robinson, Ruiying (aria) Xiong, Logan Neitzke-Spruill et al.
Background: Institutional review boards (IRBs) are gatekeepers of psychedelic research, deciding whether and under what conditions it may proceed. Yet IRB understanding, attitudes, perspectives, and concerns regarding psychedelics and psychedelic research have not previously been studied. These factors are important to assessing whether US IRBs are likely to be over- or underprotective of...